Our key assets at a glance

Data
Our technology is powered by exclusive access to diverse datasets, including hematoxylin & eosin, immunohistochemistry and FISH images, alongside clinicopathologic data and gene expression data. Using our high quality microscopy images and associated data, we develop robust and accurate state-of-the-art AI models. This comprehensive training ensures our models deliver reliable diagnostic, predictive and prognostic insights, ultimately improving patient outcomes.

Spatial
biomarker discovery
With each cancer presenting unique characteristics, precise biomarker detection becomes essential for creating personalized treatment plans. At StratifAI, we excel in biomarker detection using advanced transformer-based AI models trained on routinely available histology images. By leveraging slide-level labels, we bypass the burdensome and time-consuming manual annotation process, enabling rapid development of customized AI models. Our approach has been validated through numerous clinical studies and was recently accepted in Nature Protocols¹.

Multimodal
digital oncology
At StratifAI, we leverage the power of multimodal AI to revolutionize cancer prognostication and treatment. Our advanced models are capable of integrating data from various sources, including diverse medical imaging data and clinical records, to provide a comprehensive understanding of the tumor microenvironment and an individualized cancer characterization. Our holistic approach enables us to unlock the true potential of AI, elevating diagnostic, predictive, and prognostic accuracy to new heights.